BACKGROUND: The study of chronicity in the course of major depression has been complicated by varying definitions of this illness feature. Because familial clustering is one component of diagnostic validity we compared family clustering of chronicity as defined in the DSM-IV to that of chronicity determined by an assessment of lifetime course of depressive illness. METHODS: In 1750 affected subjects from 652 families recruited for a genetic study of recurrent, early-onset depression, we applied several definitions of chronicity. Odds ratios were determined for the likelihood of chronicity in a proband predicting chronicity in an affected relative. RESULTS: There was greater family clustering of chronicity as determined by assessment of lifetime course (OR=2.54) than by DSM-IV defined chronic major depressive episode (MDE) (OR=1.93) or dysthymic disorder (OR=1.76). In families with probands who had preadolescent onset of MDD, familiality was increased by all definitions, with a much larger increase observed for chronicity by lifetime course (ORs were 6.14 for lifetime chronicity, 2.43 for chronic MDE, and 3.42 for comorbid dysthymic disorder). Agreement between these definitions of chronicity was only fair. LIMITATIONS: The data used to determine chronicity were collected retrospectively and not blindly to relatives' status, and assessment of lifetime course was based on global clinical impressions gathered during a semi-structured diagnostic interview. Also, it can be difficult to determine whether individuals with recurrent major depressive episodes who frequently experience long periods of low grade depressive symptoms meet the strict timing requirements of DSM-IV dysthymic disorder. CONCLUSIONS: An assessment of lifetime symptom course identifies a more familial, and thus possibly a more valid, type of chronic depression than the current DSM-IV categories which are defined in terms of particular cross-sectional features of illness.
BACKGROUND: The study of chronicity in the course of major depression has been complicated by varying definitions of this illness feature. Because familial clustering is one component of diagnostic validity we compared family clustering of chronicity as defined in the DSM-IV to that of chronicity determined by an assessment of lifetime course of depressive illness. METHODS: In 1750 affected subjects from 652 families recruited for a genetic study of recurrent, early-onset depression, we applied several definitions of chronicity. Odds ratios were determined for the likelihood of chronicity in a proband predicting chronicity in an affected relative. RESULTS: There was greater family clustering of chronicity as determined by assessment of lifetime course (OR=2.54) than by DSM-IV defined chronic major depressive episode (MDE) (OR=1.93) or dysthymic disorder (OR=1.76). In families with probands who had preadolescent onset of MDD, familiality was increased by all definitions, with a much larger increase observed for chronicity by lifetime course (ORs were 6.14 for lifetime chronicity, 2.43 for chronic MDE, and 3.42 for comorbid dysthymic disorder). Agreement between these definitions of chronicity was only fair. LIMITATIONS: The data used to determine chronicity were collected retrospectively and not blindly to relatives' status, and assessment of lifetime course was based on global clinical impressions gathered during a semi-structured diagnostic interview. Also, it can be difficult to determine whether individuals with recurrent major depressive episodes who frequently experience long periods of low grade depressive symptoms meet the strict timing requirements of DSM-IV dysthymic disorder. CONCLUSIONS: An assessment of lifetime symptom course identifies a more familial, and thus possibly a more valid, type of chronic depression than the current DSM-IV categories which are defined in terms of particular cross-sectional features of illness.
Authors: Francis M Mondimore; Peter P Zandi; Dean F Mackinnon; Melvin G McInnis; Erin B Miller; Raymond P Crowe; William A Scheftner; Diana H Marta; Myrna M Weissman; Douglas F Levinson; Kathleen P Murphy-Ebenez; J Raymond Depaulo; James B Potash Journal: Am J Psychiatry Date: 2006-09 Impact factor: 18.112
Authors: James P McCullough; Daniel N Klein; Frances E Borian; Robert H Howland; Lawrence P Riso; Martin B Keller; Phillip L C Banks Journal: J Abnorm Psychol Date: 2003-11
Authors: Douglas F Levinson; George S Zubenko; Raymond R Crowe; Raymond J DePaulo; William S Scheftner; Myrna M Weissman; Peter Holmans; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; Stephanie Sassoon; James A Knowles; Jo Thomas; Jennifer Chellis Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2003-05-15 Impact factor: 3.568
Authors: Peter Holmans; George S Zubenko; Raymond R Crowe; J Raymond DePaulo; William A Scheftner; Myrna M Weissman; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; James A Knowles; Madeleine Gladis; Jo Thomas; Jennifer Chellis; Erin Miller; Douglas F Levinson Journal: Am J Hum Genet Date: 2004-04-22 Impact factor: 11.025
Authors: Carlos Blanco; Mayumi Okuda; John C Markowitz; Shang-Min Liu; Bridget F Grant; Deborah S Hasin Journal: J Clin Psychiatry Date: 2010-12 Impact factor: 4.384
Authors: William W Eaton; Huibo Shao; Gerald Nestadt; Hochang Benjamin Lee; Ben Hochang Lee; O Joseph Bienvenu; Peter Zandi Journal: Arch Gen Psychiatry Date: 2008-05
Authors: David R Strong; Amy Cameron; Shelley Feuer; Amy Cohn; Ana M Abrantes; Richard A Brown Journal: Drug Alcohol Depend Date: 2010-01-13 Impact factor: 4.492
Authors: Philip Negt; Eva-Lotta Brakemeier; Johannes Michalak; Lotta Winter; Stefan Bleich; Kai G Kahl Journal: Brain Behav Date: 2016-05-03 Impact factor: 2.708